Noul

Bio & Pharma Noul's miLab registered FDA's Class I

South Korea's Noul Co., an in-vitro diagnostics maker and artificial intelligence (AI)-based blood and cancer diagnostic platforms company, said on ...

Bio & Pharma Noul, CDC to start Malaria diagnosis project in Kenya

South Korea's Noul Co., an in-vitro diagnostics maker and artificial intelligence (AI)-based blood and cancer diagnostic platforms company, said o...

Bio & Pharma Noul to export $1.4 mn in malaria diagnostic kits to Angola

South Korean in-vitro diagnostics maker Noul Co. has signed an exclusive sales deal in Angola on the company’s malaria diagnostic platform wor...

Bio & Pharma Noul releases AI-based diagnostic gizmo for cervical cancer

Noul Co., a South Korean company specializing in artificial intelligence (AI)-based blood and cancer diagnostic platforms, has entered the cancer di...

Bio & Pharma S.Korean biotech firm Noul signs MOU with disease center of Ghana

South Korea's Medical diagnostics company Noul Co., Ltd. said on Monday that it has signed a memorandum of understanding with the Ghana Infectious D...